Atrium Innovations Inc. — Investor Relations & Filings
Filings indexed
66
across all filing types
Latest filing
2014-03-06
Regulatory Filings
Country
CA
Canada
Listing
TSX
ATB
Atrium Innovations Inc. is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products. The company's portfolio primarily consists of nutritional and dietary supplements, including specialized products, vitamins, and minerals, alongside certain cosmetic and chemical formulations. Atrium focuses on delivering professionally endorsed solutions that support a holistic approach to individualized health and healing. A key component of its operations includes providing educational resources, such as expert-led webinars, focused on advancing knowledge in natural medicine and nutrition science for healthcare practitioners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Other securityholders documents - English.pdf | 2014-03-06 | English | |
| Other securityholders documents - English.pdf | 2014-02-14 | English | |
| Material change report - French.pdf | 2014-02-14 | English | |
| Other.pdf | 2013-12-10 | English | |
| Other.pdf | 2013-12-10 | English | |
| Material change report - French.pdf | 2013-12-10 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2014
3 filings
| |||||
| 47171854 | Other securityholders documents - English.pdf | 2014-03-06 | English | ||
| 47171858 | Other securityholders documents - English.pdf | 2014-02-14 | English | ||
| 47171862 | Material change report - French.pdf | 2014-02-14 | English | ||
|
2013
7 filings
| |||||
| 47171882 | Other.pdf | 2013-12-10 | English | ||
| 47171893 | Other.pdf | 2013-12-10 | English | ||
| 47171897 | Material change report - French.pdf | 2013-12-10 | English | ||
| 47171919 | Material change report - English.pdf | 2013-10-23 | English | ||
| 47171926 | Other.pdf | 2013-10-18 | English | ||
| 47171948 | Material change report - English.pdf | 2013-10-18 | English | ||
| 47171952 | Annual information form - English.pdf | 2013-03-29 | English | ||
|
2012
2 filings
| |||||
| 47171959 | Annual information form - English.pdf | 2012-03-31 | English | ||
| 47171984 | Other.pdf | 2012-03-31 | English | ||
|
2011
3 filings
| |||||
| 47171990 | Material change report - French.pdf | 2011-10-11 | English | ||
| 47172250 | Other.pdf | 2011-09-29 | English | ||
| 47172252 | Material change report - English.pdf | 2011-08-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asymchem Laboratories (Tianjin) Co., Ltd.
A leading CDMO providing comprehensive, integrated pharmace…
|
6821 | HK | Manufacturing |
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
|
Athira Pharma, Inc.
Biopharma firm developing small molecule therapeutics for n…
|
ATHA | US | Manufacturing |
|
Atlas Global Brands Inc.
Global cannabis company spanning cultivation, manufacturing…
|
ATL | CA | Manufacturing |
|
ATOSSA THERAPEUTICS, INC.
Clinical-stage biopharmaceutical company developing oncolog…
|
ATOS | US | Manufacturing |
|
Atrium Therapeutics, Inc.
Pioneering precision RNA medicines for cardiac diseases, fo…
|
RNA | US | Manufacturing |
|
aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fib…
|
ATYR | US | Manufacturing |
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
Atrium Innovations Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45568/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45568 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45568 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45568 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45568}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Atrium Innovations Inc. (id: 45568)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.